Roivant Sciences (ROIV) News Today → The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad) Free ROIV Stock Alerts $11.33 +0.15 (+1.34%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 5:18 PM | marketbeat.comNicholas Investment Partners LP Has $1.78 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Nicholas Investment Partners LP cut its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 94.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 158,015 shares of the company's stock afterMay 7, 2024 | investorplace.comBiotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareMay 1, 2024 | investorplace.com3 Healthcare Stocks With the Potential to Triple Your Investment by 2026April 28, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Short Interest UpdateRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 45,130,000 shares, an increase of 45.9% from the March 31st total of 30,930,000 shares. Approximately 8.2% of the company's stock are sold short. Based on an average trading volume of 7,280,000 shares, the days-to-cover ratio is currently 6.2 days.April 26, 2024 | marketbeat.comabrdn plc Makes New $12.66 Million Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)abrdn plc purchased a new position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,126,987 shares of the company's stock, valued aApril 25, 2024 | businesswire.comRoivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary SarcoidosisApril 24, 2024 | seekingalpha.comRoivant Sciences: Cashing In On Vants And VenturesApril 22, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $18.00 price target on shares of Roivant Sciences in a research note on Monday.April 14, 2024 | markets.businessinsider.comSunrun (RUN) Gets a Buy from RBC CapitalApril 8, 2024 | marketbeat.comVanguard Group Inc. Has $65.44 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Vanguard Group Inc. increased its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 159.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,602,566 shares of the company's stock after purchaApril 5, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Roivant Sciences Ltd.'s Q1 2025 Earnings (NASDAQ:ROIV)Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) - HC Wainwright lowered their Q1 2025 earnings per share estimates for Roivant Sciences in a research note issued on Wednesday, April 3rd. HC Wainwright analyst D. Tsao now expects that the company will earn ($0.25) per share for the quarter, downApril 4, 2024 | msn.comRoivant's anti-inflammatory drug shows promise in mid-stage studyApril 3, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Sees Large Volume Increase Following Analyst UpgradeRoivant Sciences (NASDAQ:ROIV) Sees Large Volume Increase After Analyst UpgradeApril 3, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Given New $18.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group increased their price objective on shares of Roivant Sciences from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Wednesday.April 3, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by AnalystsRoivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten research firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and nine have given a buy recommendationApril 2, 2024 | marketbeat.comRoivant Sciences Sees Unusually High Options Volume (NASDAQ:ROIV)Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders purchased 11,070 call options on the stock. This represents an increase of 209% compared to the typical daily volume of 3,588 call options.April 2, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.43Roivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.43April 2, 2024 | msn.comRoivant Sciences Stock Flirts With Breakout On 'Extremely Positive' Eye-Disease StudyApril 2, 2024 | reuters.comRoivant's anti-inflammatory drug succeeds in mid-stage studyApril 2, 2024 | globenewswire.comRoivant Announces Positive NEPTUNE Study Results for Brepocitinib in NIU, as well as Board Authorization for up to $1.5 Billion Share Repurchase Program, Including Repurchase of Entire Sumitomo Pharma Stake for $648 MillionApril 1, 2024 | msn.comCompare with CoinDesk Market Index (CDICMI)March 29, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $11.94 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Assenagon Asset Management S.A. lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 195.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,063,392 shares of the company's stock after acquiMarch 28, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Shares Down 4% Roivant Sciences (NASDAQ:ROIV) Trading Down 4%March 27, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.08Roivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.08March 26, 2024 | msn.comViking Therapeutics gains on early data for oral weight loss therapyMarch 26, 2024 | msn.com'Some people have principles': Internet divided as Vivek Ramaswamy predicts NY ruling against Trump could energize key voter groupMarch 25, 2024 | marketbeat.comTruist Financial Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)Truist Financial restated a "buy" rating and set a $23.00 target price on shares of Roivant Sciences in a research report on Monday.March 21, 2024 | marketbeat.comRoivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.01Roivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.01March 17, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by Citigroup Inc.Citigroup Inc. increased its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 45.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 326,431 shares of the company's stock after purcMarch 16, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by Wellington Management Group LLPWellington Management Group LLP reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 2.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,842,976 shares of theMarch 15, 2024 | marketbeat.comInvestors Purchase Large Volume of Roivant Sciences Put Options (NASDAQ:ROIV)Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) was the recipient of some unusual options trading activity on Friday. Stock traders bought 30,219 put options on the stock. This is an increase of approximately 883% compared to the typical daily volume of 3,073 put options.March 14, 2024 | fr.investing.comL'objectif de cours de Roivant Sciences relevé à 16$ par Goldman SachsMarch 14, 2024 | marketbeat.comMorgan Stanley Buys 6,324,915 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Morgan Stanley grew its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 48.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,311,631 shares of the company's stock after acquiring an additionMarch 13, 2024 | edition.cnn.comTravere Therapeutics, Inc.March 13, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV)March 12, 2024 | marketbeat.comCalifornia State Teachers Retirement System Sells 101,449 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)California State Teachers Retirement System cut its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 26.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 280,746 shares of the company's stock after selling 101,449 sMarch 6, 2024 | marketbeat.comTejara Capital Ltd Has $4.19 Million Stake in Roivant Sciences Ltd. (NASDAQ:ROIV)Tejara Capital Ltd lifted its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 49.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 358,572 shares of the company's stock after acquiringMarch 5, 2024 | marketbeat.comRegal Partners Ltd Acquires Shares of 100,000 Roivant Sciences Ltd. (NASDAQ:ROIV)Regal Partners Ltd acquired a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund acquired 100,000 shares of the company's stock, valued at approximately $1,168,000. Several other institutionalMarch 4, 2024 | marketbeat.comLaurion Capital Management LP Trims Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Laurion Capital Management LP lessened its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 39.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,035,447 shares of the company's stock after selling 667,215 shareMarch 3, 2024 | marketbeat.comArdsley Advisory Partners LP Has $5.26 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Ardsley Advisory Partners LP lessened its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 18.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 450,000 shares of the company's stock after selling 104,0March 1, 2024 | marketbeat.comBank of Nova Scotia Makes New Investment in Roivant Sciences Ltd. (NASDAQ:ROIV)Bank of Nova Scotia purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 978,315 shares of the company's stock, valued at approximately $11,427,000. Bank ofFebruary 28, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series CDeerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of thFebruary 27, 2024 | marketbeat.comAvidity Partners Management LP Decreases Position in Roivant Sciences Ltd. (NASDAQ:ROIV)Avidity Partners Management LP lessened its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 10.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,503,302 shares of the compFebruary 25, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Position Boosted by Monashee Investment Management LLCMonashee Investment Management LLC lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 37.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 550,000 shares of the company's stock after buyingFebruary 23, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $22.47 Million Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV)Charles Schwab Investment Management Inc. boosted its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 207.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,923,879 shares of the company'February 21, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Citigroup Inc.Citigroup Inc. boosted its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 45.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 326,431 shares of the company's stock after purchasing an adFebruary 20, 2024 | marketbeat.comFmr LLC Purchases 2,913,491 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV)Fmr LLC lifted its position in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 8.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 38,910,625 shares of the company's stock after buying an adFebruary 18, 2024 | marketbeat.comSilverarc Capital Management LLC Invests $1.17 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)Silverarc Capital Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company's stock, valued at appFebruary 17, 2024 | marketbeat.comRoivant Sciences Ltd. (NASDAQ:ROIV) Shares Sold by State of New Jersey Common Pension Fund DState of New Jersey Common Pension Fund D lowered its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 18.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 215,750 shares of the company's stock aftFebruary 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Roivant Sciences: Undervaluation and Promising Pipeline Drive Positive Outlook Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. ROIV Media Mentions By Week ROIV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ROIV News Sentiment▼1.430.57▲Average Medical News Sentiment ROIV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ROIV Articles This Week▼25▲ROIV Articles Average Week Get Roivant Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ROIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VKTX News Today LEGN News Today CTLT News Today ASND News Today CERE News Today JAZZ News Today ITCI News Today CYTK News Today ELAN News Today BPMC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ROIV) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsAmerica’s worst nightmare?Porter & CompanyInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperHow to Make 100X on the AI BoomInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
